Archives: Blog

Blog news and reviews

Group B Strep ICD 10 – Coding & Billing Solutions

2024 ICD-10-CM Diagnosis Code A40.1

Group B Strep ICD 10 Sepsis due to streptococcus, group B

  • A40.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM A40.1 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of A40.1 – other international versions of ICD-10 A40.1 may differ.

The following code(s) above A40.1 contain annotation back-references

that may be applicable to A40.1:

  • A00-B99 – Certain infectious and parasitic diseases
  • A40 – Streptococcal sepsis

Approximate Synonyms

  • Sepsis due to streptococcus agalactiae
  • Sepsis with septicemia
  • Septic shock with acute organ dysfunction
  • Septic shock with acute organ dysfunction due to group b streptococcus
  • Severe sepsis with acute organ dysfunction
  • Severe sepsis with acute organ dysfunction due to group b streptococcus

ICD-10-CM A40.1 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 870 Septicemia or severe sepsis with mv >96 hours
  • 871 Septicemia or severe sepsis without mv >96 hours with mcc
  • 872 Septicemia or severe sepsis without mv >96 hours without mcc

Convert A40.1 to ICD-9-CM

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to A40.1:

Sepsis (generalized) (unspecified organism) A41.9

Streptococcus, streptococcal A40.9

group

B A40.1

agalactiae A40.1

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

To learn more about Group B Strep ICD 10, contact us today.

ICD 10 Juvenile Arthritis Codes – Coding & Billing Solutions

2024 ICD-10-CM Diagnosis Code M08.9

Juvenile arthritis, unspecified

M08.9 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.

The 2024 edition of ICD-10-CM M08.9 became effective on October 1, 2023.

This is the American ICD-10-CM version of M08.9 – other international versions of ICD-10 M08.9 may differ.

Type 1 Excludes

  • Juvenile rheumatoid arthritis, unspecified (M08.0-)

The following code(s) above M08.9 contain annotation back-references

that may be applicable to M08.9:

  • M00-M99 – Diseases of the musculoskeletal system and connective tissue
  • M08 – Juvenile arthritis

Clinical Information

Rheumatoid arthritis of children occurring in three major subtypes defined by the symptoms present during the first six months following onset: systemic onset (still’s disease, juvenile onset), polyarticular onset, and pauciarticular onset; adult onset cases of still’s disease (still’s disease, adult onset) are also known; only one subtype of juvenile rheumatoid arthritis (polyarticular onset, rheumatoid factor positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Sickle Cell Anemia ICD 10 Code Overview

Sickle Cell Anemia ICD 10 Code Overview

Use Additional

  • code for any associated fever (R50.81)

Type 1 Excludes

  • other hemoglobinopathies (D58.-)

Clinical Information

  • A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.
  • A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin s.
  • An inherited disease in which the red blood cells have an abnormal crescent shape, block small blood vessels, and do not last as long as normal red blood cells. Sickle cell anemia is caused by a mutation (change) in one of the genes for hemoglobin (the substance inside red blood cells that binds to oxygen and carries it from the lungs to the tissues). It is most common in people of west and central african descent.
  • Disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs; the clinical expression of homozygosity for hemoglobin s.
  • Sickle cell anemia is a disease in which your body produces abnormally shaped red blood cells. The cells are shaped like a crescent or sickle. They don’t last as long as normal, round red blood cells, which leads to anemia. The sickle cells also get stuck in blood vessels, blocking blood flow. This can cause pain and organ damage. A genetic problem causes sickle cell anemia. People with the disease are born with two sickle cell genes, one from each parent. If you only have one sickle cell gene, it’s called sickle cell trait. About 1 in 12 african americans has sickle cell trait. A blood test can show if you have the trait or anemia. Most states test newborn babies as part of their newborn screening programs.

Codes

D57 Sickle-cell disorders

D57.0 Hb-SS disease with crisis

D57.00 …… unspecified

D57.01 Hb-SS disease with acute chest syndrome

D57.02 Hb-SS disease with splenic sequestration

D57.03 Hb-SS disease with cerebral vascular involvement

D57.09 …… with other specified complication

D57.1 Sickle-cell disease without crisis

D57.2 Sickle-cell/Hb-C disease

D57.20 …… without crisis

D57.21 Sickle-cell/Hb-C disease with crisis

D57.211 Sickle-cell/Hb-C disease with acute chest syndrome

D57.212 Sickle-cell/Hb-C disease with splenic sequestration

D57.213 Sickle-cell/Hb-C disease with cerebral vascular involvement

D57.218 …… with other specified complication

D57.219 …… unspecified

D57.3 Sickle-cell trait

D57.4 Sickle-cell thalassemia

D57.40 …… without crisis

D57.41 Sickle-cell thalassemia, unspecified, with crisis

D57.411 Sickle-cell thalassemia, unspecified, with acute chest syndrome

D57.412 Sickle-cell thalassemia, unspecified, with splenic sequestration

D57.413 Sickle-cell thalassemia, unspecified, with cerebral vascular involvement

D57.418 …… with other specified complication

D57.419 Sickle-cell thalassemia, unspecified, with crisis

D57.42 …… beta zero without crisis

D57.43 Sickle-cell thalassemia beta zero with crisis

D57.431 Sickle-cell thalassemia beta zero with acute chest syndrome

D57.432 Sickle-cell thalassemia beta zero with splenic sequestration

D57.433 Sickle-cell thalassemia beta zero with cerebral vascular involvement

D57.438 …… with other specified complication

D57.439 …… unspecified

D57.44 …… beta plus without crisis

D57.45 Sickle-cell thalassemia beta plus with crisis

D57.451 Sickle-cell thalassemia beta plus with acute chest syndrome

D57.452 Sickle-cell thalassemia beta plus with splenic sequestration

D57.453 Sickle-cell thalassemia beta plus with cerebral vascular involvement

D57.458 …… with other specified complication

D57.459 …… unspecified

D57.8 Other sickle-cell disorders

D57.80 …… without crisis

D57.81 Other sickle-cell disorders with crisis

D57.811 Other sickle-cell disorders with acute chest syndrome

D57.812 Other sickle-cell disorders with splenic sequestration

D57.813 Other sickle-cell disorders with cerebral vascular involvement

D57.818 …… with other specified complication

D57.819 …… unspecified

If your organization is falling behind on coding and billing or just needs some fresh eyes, the Coding & Billing Solutions Team is ready to help. Contact us today!

AIDS ICD 10 Codes – Coding & Billing Solutions

In this post, we detail the AIDS ICD 10 Codes.

ICD-10-CM Codes › A00-B99 › B20-B20 › B20- › 2024 ICD-10-CM Diagnosis Code B20

2024 ICD-10-CM Diagnosis Code B20

Human immunodeficiency virus [HIV] disease

  • B20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM B20 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of B20 – other international versions of ICD-10 B20 may differ.

Use Additional

  • code(s) to identify all manifestations of HIV infection

Code First

  • Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium, if applicable (O98.7-)

Type 1 Excludes

  • asymptomatic human immunodeficiency virus [HIV] infection status (Z21)
  • exposure to HIV virus (Z20.6)
  • inconclusive serologic evidence of HIV (R75)

Includes

  • acquired immune deficiency syndrome [AIDS]
  • AIDS-related complex [ARC]
  • HIV infection, symptomatic

The following code(s) above B20 contain annotation back-references

that may be applicable to B20:

A00-B99 – Certain infectious and parasitic diseases

Approximate Synonyms

  • Acquired immune deficiency syndrome (AIDS) in childbirth
  • Acquired immune deficiency syndrome (AIDS) postpartum
  • Acquired immune deficiency syndrome with pregnancy
  • Acquired immune deficiency syndrome-related nephropathy
  • AIDS
  • AIDS dementia complex
  • AIDS in childbirth
  • AIDS wasting disease
  • AIDS with dementia
  • AIDS with neuropathy (nerve disease)
  • AIDS with polyneuropathy (multiple nerve disease)
  • AIDS, cdc stage a3
  • AIDS, cdc stage b3
  • AIDS, cdc stage c1
  • AIDS, cdc stage c2
  • AIDS, cdc stage c3
  • Cachexia associated with AIDS
  • Cognitive impairment due to human immunodeficiency virus infection
  • Dementia associated with AIDS
  • HIV cdc category a3 (AIDS)
  • HIV cdc category b3 (AIDS)
  • HIV cdc category c1 (AIDS)
  • HIV cdc category c2 (AIDS)
  • HIV cdc category c3 (AIDS)
  • HIV in pregnancy
  • HIV infection symptomatic
  • HIV infection symptomatic b1
  • HIV infection symptomatic b2
  • HIV lipoatrophy
  • HIV related cognitive impairment
  • HIV related non hodgkins lymphoma
  • HIV1 infection, symptomatic
  • Human immunodeficiency virus myelitis
  • Lipoatrophy due to HIV infection and treatment
  • Myelitis due to HIV
  • Nephropathy due to HIV
  • Neuropathy due to human immunodeficiency virus
  • Non-hodgkin lymphoma associated with human immunodeficiency virus infection
  • Polyneuropathy associated with AIDS
  • Postpartum AIDS (after childbirth)
  • Symptomatic human immunodeficiency virus (HIV) 1 infection
  • Symptomatic human immunodeficiency virus (HIV) infection category b1
  • Symptomatic human immunodeficiency virus (HIV) infection category b2
  • Symptomatic human immunodeficiency virus infection

Clinical Information

  • A disease caused by human immunodeficiency virus (HIV). People with acquired immunodeficiency syndrome are at an increased risk for developing certain cancers and for infections that usually occur only in individuals with a weak immune system.
  • A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (arc) from AIDS include elevated or hyperactive b-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of kaposi’s sarcoma, signaling the transition to the full-blown AIDS.
  • A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the helper t-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (cmv) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-hodgkin’s lymphoma and kaposi’s sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.
  • An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a cd4-positive t-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the cdc in 1993.
  • An infection caused by the human immunodeficiency virus.
  • Any state of infection accompanied by evidence of HIV in the body (positive test for HIV genome, cdna, proteins, antigens, or antibodies); may be medically asymptomatic or symptomatic; use AIDS when appropriate.
  • Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, through AIDS-related complex (arc), to acquired immunodeficiency syndrome (AIDS).
  • One or more indicator diseases, depending on laboratory evidence of HIV infection (cdc); late phase of HIV infection characterized by marked suppression of immune function resulting in opportunistic infections, neoplasms, and other systemic symptoms (niaid).

ICD-10-CM B20 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 969 HIV with extensive o.r. Procedures with mcc
  • 970 HIV with extensive o.r. Procedures without mcc
  • 974 HIV with major related condition with mcc
  • 975 HIV with major related condition with cc
  • 976 HIV with major related condition without cc/mcc
  • 977 HIV with or without other related condition
  • 974 HIV with major related condition with mcc
  • 975 HIV with major related condition with cc
  • 976 HIV with major related condition without cc/mcc

Convert B20 to ICD-9-CM

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Code annotations containing back-references to B20:

Code Also: I27.21

Code First: B39, C46, F02, F06.7, G05

Type 1 Excludes: I88, B97.3, D61.81, L04, D84.81, D89.89, R62.5, R75, Z21, Z21

Applicable To: Z83.0

Use Additional: O98.7, O98.7, D59.31

Diagnosis Index entries containing back-references to B20:

  • Acquired – see also condition

immunodeficiency syndrome B20 (AIDS)

  • AIDS B20 (related complex)
  • ARC B20 (AIDS-related complex)
  • Dementia (degenerative (primary)) (old age) (persisting) (unspecified severity) (without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety) F03.90 in (due to) human immunodeficiency virus (HIV) B20 – see also Dementia, in, diseases specified elsewhere with behavioral disturbance B20 – see also Dementia, in, diseases specified elsewhere.
  • Disease, diseased – see also Syndrome

viral, virus B34.9

– see also Disease, by type of virus

human immunodeficiency B20 (HIV)

human immunodeficiency virus B20 (HIV)

slim B20 (HIV)

  • Encephalitis (chronic) (hemorrhagic) (idiopathic) (nonepidemic) (spurious) (subacute) G04.90 due to human immunodeficiency virus B20 (HIV)

HIV B20 – see also Human, immunodeficiency virus.

Human

immunodeficiency virus (HIV) disease (infection) B20

dementia B20 – see also Dementia, in, diseases specified elsewhere with behavioral disturbance B20 – see also Dementia, in, diseases specified elsewhere.

Slim disease B20 (in HIV infection)

Syndrome – see also Disease

HIV infection, acute B20

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

ICD 10 Code for HIV – Coding & Billing Solutions

ICD-10-CM Codes › A00-B99 › B20-B20 › Human immunodeficiency virus [HIV] disease B20 Human immunodeficiency virus [HIV] disease B20- Use Additional code(s) to identify all manifestations of HIV infection Code First Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium, if applicable (O98.7-)

Type 1 Excludes

  • Asymptomatic human immunodeficiency virus [HIV] infection status (Z21)
  • Exposure to HIV virus
  • Inconclusive serologic evidence of HIV (R75)

Includes

  • Acquired immune deficiency syndrome [AIDS]
  • AIDS-related complex [ARC]
  • HIV infection, symptomatic

Clinical Information

  • A disease caused by human immunodeficiency virus (HIV). People with acquired immunodeficiency syndrome are at an increased risk for developing certain cancers and for infections that usually occur only in individuals with a weak immune system.
  • A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating aids-related complex (arc) from aids include elevated or hyperactive b-cell humoral immune responses, compared to depressed or normal antibody reactivity in aids; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of aids; evolving succession of histopathological lesions such as localization of Kaposi’s sarcoma, signaling the transition to the full-blown aids.
  • A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the helper t-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with aids are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (cmv) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin’s lymphoma and Kaposi’s sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.
  • An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a cd4-positive t-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for aids as defined by the cdc in 1993.
  • An infection caused by the human immunodeficiency virus.
  • Any state of infection accompanied by evidence of HIV in the body (positive test for HIV genome, cdna, proteins, antigens, or antibodies); may be medically asymptomatic or symptomatic; use aids when appropriate.
  • Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru aids-related complex (arc), to acquired immunodeficiency syndrome (aids).
  • One or more indicator diseases, depending on laboratory evidence of HIV infection (cdc); late phase of HIV infection characterized by marked suppression of immune function resulting in opportunistic infections, neoplasms, and other systemic symptoms (niaid).

Preeclampsia ICD 10 Codes – Coding & Billing Solutions

2024 ICD-10-CM Diagnosis Code O14.90

Unspecified pre-eclampsia, unspecified trimester

O14.90 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

  • The 2024 edition of ICD-10-CM O14.90 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of O14.90 – other international versions of ICD-10 O14.90 may differ.

ICD-10-CM Coding Rules

  • O14.90 is applicable to maternity patients aged 12 – 55 years inclusive.
  • O14.90 is applicable to female patients.

The following code(s) above O14.90 contain annotation back-references

that may be applicable to O14.90:

  • O00-O9A    Pregnancy, childbirth and the puerperium
  • O14    Pre-eclampsia

Approximate Synonyms

  • Postpartum preeclampsia (high blood pressure and protein in urine, after childbirth)
  • Postpartum preeclampsia (high blood pressure and protein in urine,after childbirth)
  • Pre-eclampsia
  • Pre-eclampsia postpartum
  • Preeclampsia (high blood pressure and protein in urine during pregnancy)

Clinical Information

  • A complication of pregnancy, characterized by a complex of symptoms including maternal hypertension and proteinuria with or without pathological edema. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation but may develop before this time in the presence of trophoblastic disease.
  • A condition of hypertension occurring in pregnancy
  • A pregnancy induced hypertensive state that occurs after 20 weeks of gestation characterized by an increase in blood pressure, along with body swelling and proteinuria.
  • A pregnancy-related disorder characterized by an increase in the blood pressure after the twentieth week of gestation, and by the presence of proteinuria. It may appear up to six weeks post-partum. It may lead to eclampsia with development of tonic-clonic seizures.
  • Pregnancy induced hypertensive states, including eph gestosis when edema and proteinuria accompany hypertension; other hypertensive disorders that develop during pregnancy or the puerperium are preeclampsia and eclampsia, either of which may be superimposed upon chronic hypertensive vascular or renal disease.
  • Toxemia occurring in women in the second half of their pregnancy, characterized by hypertension, and usually by edema and proteinuria, but without the convulsions and coma associated with eclampsia.

ICD-10-CM O14.90 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 817 Other antepartum diagnoses with o.r. Procedures with mcc
  • 818 Other antepartum diagnoses with o.r. Procedures with cc
  • 819 Other antepartum diagnoses with o.r. Procedures without cc/mcc
  • 831 Other antepartum diagnoses without o.r. Procedures with mcc
  • 832 Other antepartum diagnoses without o.r. Procedures with cc
  • 833 Other antepartum diagnoses without o.r. Procedures without cc/mcc

Convert O14.90 to ICD-9-CM

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

If you would like to learn more about Preeclampsia ICD 10 Codes, please call us at 610-428-9034 or fill out our Contact Form.

Cystic Fibrosis ICD 10 Codes – Coding & Billing Solutions

2024 ICD-10-CM Diagnosis Code E84.0

Cystic fibrosis with pulmonary manifestations

E84.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

  • The 2024 edition of ICD-10-CM E84.0 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of E84.0 – other international versions of ICD-10 E84.0 may differ.

Use additional code to identify any infectious organism present, such as:

Pseudomonas (B96.5)

The following code(s) above E84.0 contain annotation back-references

that may be applicable to E84.0:

E00-E89 Endocrine, nutritional, and metabolic diseases

E70-E88  Metabolic disorders

E84    Cystic fibrosis

Approximate Synonyms

  • Cystic fibrosis of the lung
  • Cystic fibrosis, pulmonary

ICD-10-CM E84.0 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 177 Respiratory infections and inflammations with mcc
  • 178 Respiratory infections and inflammations with cc
  • 179 Respiratory infections and inflammations without cc/mcc

Convert E84.0 to ICD-9-CM

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Code annotations containing back-references to E84.0:

Code Also: I27.23

Type 1 Excludes: J99, P78, Q33.0, Q45.3

Diagnosis Index entries containing back-references to E84.0:

Fibrosis, fibrotic cystic (of pancreas) E84.9 with pulmonary manifestations E84.0

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

If you would like to learn more about Cystic Fibrosis ICD 10 Codes, please call us at 610-428-9034 or fill out our Contact Form.

Brain Cancer ICD 10 Codes – Coding & Billing Solutions

ICD-10-CM Codes, C00-D49, C69-C72, Malignant neoplasm of the brain C71

Malignant neoplasm of the brain C71-

Type 1 Excludes

  • malignant neoplasm of cranial nerves (C72.2-C72.5)
  • retrobulbar malignant neoplasm (C69.6-)

Clinical Information

  • A primary or metastatic malignant neoplasm affects the brain.
  • Cancer of the brain is usually called a brain tumor. There are two main types. A primary brain tumor starts in the brain. A metastatic brain tumor starts somewhere else in the body and moves to the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Brain tumors can cause many symptoms. Some common symptoms include:
    • headaches, usually worse in the morning.
    • nausea and vomiting.
    • changes in your ability to talk, hear, or see.
    • problems with balance or walking.
    • problems with thinking or memory .
    • muscle jerking or twitching.
    • numbness or tingling in arms or legs.

Physicians diagnose brain tumors by doing a neurologic exam and tests including an MRI, CT Scan, and biopsy. People with brain tumors have several treatment options. The options are surgery, radiation therapy, and chemotherapy. Many people get a combination of treatments.

Codes

C71 Malignant neoplasm of brain

C71.0 Malignant neoplasm of cerebrum, except lobes and ventricles

C71.1 Malignant neoplasm of frontal lobe

C71.2 Malignant neoplasm of temporal lobe

C71.3 Malignant neoplasm of parietal lobe

C71.4 Malignant neoplasm of occipital lobe

C71.5 Malignant neoplasm of cerebral ventricle

C71.6 Malignant neoplasm of cerebellum

C71.7 Malignant neoplasm of brain stem

C71.8 Malignant neoplasm of overlapping sites of brain

C71.9 Malignant neoplasm of brain, unspecified

If you would like to learn more about Brain Cancer ICD 10 Codes, please call us at 610-428-9034 or fill out our Contact Form.

Bladder Cancer ICD 10 Codes – Coding & Billing Solutions

ICD-10-CM Codes › C00-D49 › C64-C68 › Malignant neoplasm of bladder C67

Malignant neoplasm of the bladder C67

Clinical Information

A primary or metastatic malignant neoplasm involving the bladder.

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.

Symptoms include:

  • blood in your urine.
  • a frequent urge to urinate.
  • pain when you urinate.
  • low back pain.

Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body’s own ability to fight cancer.

Codes

  • C67 Malignant neoplasm of bladder
  • C67.0 Malignant neoplasm of trigone of bladder
  • C67.1 Malignant neoplasm of dome of bladder
  • C67.2 Malignant neoplasm of lateral wall of bladder
  • C67.3 Malignant neoplasm of anterior wall of bladder
  • C67.4 Malignant neoplasm of posterior wall of bladder
  • C67.5 Malignant neoplasm of bladder neck
  • C67.6 Malignant neoplasm of ureteric orifice
  • C67.7 Malignant neoplasm of urachus
  • C67.8 Malignant neoplasm of overlapping sites of bladder
  • C67.9 Malignant neoplasm of bladder, unspecified

If you would like to learn more about Bladder Cancer ICD 10 Codes, please call us at 610-428-9034 or fill out our Contact Form.

Melanoma ICD 10 Codes – Coding & Billing Solutions

ICD-10-CM Codes › C00-D49 › C43-C4A › Malignant melanoma of skin C43

Malignant melanoma of skin C43-

Type 1 Excludes melanoma in situ (D03.-)

Type 2 Excludes

malignant melanoma of skin of genital organs (C51-C52, C60., C63.-)

  • Merkel cell carcinoma (C4A.-)
  • sites other than skin-code to malignant neoplasm of the site

Clinical Information

A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.

Codes

  1. C43 Malignant melanoma of skin
  2. C43.0 Malignant melanoma of lip
  3. C43.1 Malignant melanoma of eyelid, including canthus
    • C43.10 Malignant melanoma of unspecified eyelid, including canthus
    • C43.11 Malignant melanoma of right eyelid, including canthus
    • C43.111 Malignant melanoma of right upper eyelid, including canthus
    • C43.112 Malignant melanoma of right lower eyelid, including canthus
    • C43.12 Malignant melanoma of left eyelid, including canthus
    • C43.121 Malignant melanoma of left upper eyelid, including canthus
    • C43.122 Malignant melanoma of left lower eyelid, including canthus
  4. C43.2 Malignant melanoma of ear and external auricular canal
    • C43.20 Malignant melanoma of unspecified ear and external auricular canal
    • C43.21 Malignant melanoma of right ear and external auricular canal
    • C43.22 Malignant melanoma of left ear and external auricular canal
  5. C43.3 Malignant melanoma of other and unspecified parts of face
    • C43.30 Malignant melanoma of unspecified part of face
    • C43.31 Malignant melanoma of nose
    • C43.39 Malignant melanoma of other parts of face
  6. C43.4 Malignant melanoma of scalp and neck
  7. C43.5 Malignant melanoma of trunk
    • C43.51 Malignant melanoma of anal skin
    • C43.52 Malignant melanoma of skin of breast
    • C43.59 Malignant melanoma of other part of trunk
  8. C43.6 Malignant melanoma of upper limb, including shoulder
    • C43.60 Malignant melanoma of unspecified upper limb, including shoulder
    • C43.61 Malignant melanoma of right upper limb, including shoulder
    • C43.62 Malignant melanoma of left upper limb, including shoulder
  9. C43.7 Malignant melanoma of lower limb, including hip
    • C43.70 Malignant melanoma of unspecified lower limb, including hip
    • C43.71 Malignant melanoma of right lower limb, including hip
    • C43.72 Malignant melanoma of left lower limb, including hip
  10. C43.8 Malignant melanoma of overlapping sites of skin
  11. C43.9 Malignant melanoma of skin, unspecified

If you would like to learn more about Multiple Myeloma ICD 10 Codes, please call us at 610-428-9034 or fill out our Contact Form.

Copyright © 2025 Coding & Billing Solutions | Established 2010 in Pennsburg, PA | Privacy Policy